Focal Segmental Glomerulosclerosis
- PMID: 28242845
- PMCID: PMC5338705
- DOI: 10.2215/CJN.05960616
Focal Segmental Glomerulosclerosis
Erratum in
-
Correction.Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1889. doi: 10.2215/CJN.12071018. Epub 2018 Nov 9. Clin J Am Soc Nephrol. 2018. PMID: 30413403 Free PMC article. No abstract available.
Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant-important disease characteristics. In contrast, adaptive FSGS is associated with excessive nephron workload due to increased body size, reduced nephron capacity, or single glomerular hyperfiltration associated with certain diseases. Additional etiologies are now recognized as drivers of FSGS: high-penetrance genetic FSGS due to mutations in one of nearly 40 genes, virus-associated FSGS, and medication-associated FSGS. Emerging data support the identification of a sixth category: APOL1 risk allele-associated FSGS in individuals with sub-Saharan ancestry. The classification of a particular patient with FSGS relies on integration of findings from clinical history, laboratory testing, kidney biopsy, and in some patients, genetic testing. The kidney biopsy can be helpful, with clues provided by features on light microscopy (e.g, glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence (e.g, to rule out other primary glomerulopathies), and electron microscopy (e.g., extent of podocyte foot process effacement, podocyte microvillous transformation, and tubuloreticular inclusions). A complete assessment of renal histology is important for establishing the parenchymal setting of segmental glomerulosclerosis, distinguishing FSGS associated with one of many other glomerular diseases from the clinical-pathologic syndrome of FSGS. Genetic testing is beneficial in particular clinical settings. Identifying the etiology of FSGS guides selection of therapy and provides prognostic insight. Much progress has been made in our understanding of FSGS, but important outstanding issues remain, including the identity of the plasma factor believed to be responsible for primary FSGS, the value of routine implementation of genetic testing, and the identification of more effective and less toxic therapeutic interventions for FSGS.
Keywords: Alleles; Biopsy; Body Size; Electron; Fluorescent Antibody Technique; Focal Segmental; Genetic Testing; Glomerulosclerosis; Humans; Kidney Diseases; Kidney Glomerulus; Microscopy; Mutation; Penetrance; Podocytes; Segmental glomerulosclerosis; Workload; hypertrophy; immunosuppression; kidney; kidney transplantation; nephrotic syndrome.
Copyright © 2017 by the American Society of Nephrology.
Figures
![Figure 1.](http://178.128.105.246/cars-https-www.ncbi.nlm.nih.gov/pmc/articles/instance/5338705/bin/CJN.05960616f1.gif)
![Figure 2.](http://178.128.105.246/cars-https-www.ncbi.nlm.nih.gov/pmc/articles/instance/5338705/bin/CJN.05960616f2.gif)
Similar articles
-
Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.Nephron. 2020;144 Suppl 1:65-70. doi: 10.1159/000510748. Epub 2020 Dec 1. Nephron. 2020. PMID: 33260184 Review.
-
Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective.Nephron. 2020;144(9):413-427. doi: 10.1159/000508099. Epub 2020 Jul 28. Nephron. 2020. PMID: 32721952 Review.
-
Focal segmental glomerulosclerosis complicating solitary kidney.Clin Exp Nephrol. 2009 Feb;13(1):81-4. doi: 10.1007/s10157-008-0076-z. Epub 2008 Aug 9. Clin Exp Nephrol. 2009. PMID: 18688570
-
Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Results From the Chronic Kidney Disease in Children (CKiD) Cohort.Am J Kidney Dis. 2023 Jun;81(6):635-646.e1. doi: 10.1053/j.ajkd.2022.11.003. Epub 2023 Jan 6. Am J Kidney Dis. 2023. PMID: 36623684
-
Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis.Clin J Am Soc Nephrol. 2020 Jul 1;15(7):964-972. doi: 10.2215/CJN.00590120. Epub 2020 May 22. Clin J Am Soc Nephrol. 2020. PMID: 32444394 Free PMC article.
Cited by
-
Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases.Clin Kidney J. 2024 Jul 10;17(8):sfae215. doi: 10.1093/ckj/sfae215. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39135935 Free PMC article. Review.
-
Potential biomarkers of recurrent FSGS: a review.BMC Nephrol. 2024 Aug 12;25(1):258. doi: 10.1186/s12882-024-03695-8. BMC Nephrol. 2024. PMID: 39134955 Free PMC article. Review.
-
The IRE1α pathway in glomerular diseases: The unfolded protein response and beyond.Front Mol Med. 2022 Sep 26;2:971247. doi: 10.3389/fmmed.2022.971247. eCollection 2022. Front Mol Med. 2022. PMID: 39086958 Free PMC article. Review.
-
Unmasking Focal Segmental Glomerulosclerosis in a Patient With Lupus Nephritis.Cureus. 2024 Jun 24;16(6):e63008. doi: 10.7759/cureus.63008. eCollection 2024 Jun. Cureus. 2024. PMID: 39050286 Free PMC article.
-
INF2 formin variants linked to human inherited kidney disease reprogram the transcriptome, causing mitotic chaos and cell death.Cell Mol Life Sci. 2024 Jun 25;81(1):279. doi: 10.1007/s00018-024-05323-y. Cell Mol Life Sci. 2024. PMID: 38916773 Free PMC article.
References
-
- D’Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med 365: 2398–2411, 2011 - PubMed
-
- Sethi S, Glassock RJ, Fervenza FC: Focal segmental glomerulosclerosis: Towards a better understanding for the practicing nephrologist. Nephrol Dial Transplant 30: 375–384, 2015 - PubMed
-
- D’Agati VD: Pathobiology of focal segmental glomerulosclerosis: New developments. Curr Opin Nephrol Hypertens 21: 243–250, 2012 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous